Skip to main content
Clinical Trials/NCT04385758
NCT04385758
Completed
Not Applicable

Community Paramedicine Program to Improve Diabetes Care Quality, Equity, and Outcomes

Mayo Clinic1 site in 1 country86 target enrollmentJuly 13, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes
Sponsor
Mayo Clinic
Enrollment
86
Locations
1
Primary Endpoint
Diabetes Distress (using DDS)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is evaluate the effectiveness of Diabetes-REM (Rescue, Engagement, and Management), a comprehensive community paramedic (CP) program to support adults in Southeast Minnesota (Mower, Freeborn, and Olmsted counties) and Northwest Wisconsin (Barron, Rusk, and Dunn) who have uncontrolled diabetes (HbA1c ≥ 9%) and have experienced an emergency department (ED) visit or hospitalization for any cause in the prior 6 months.

Registry
clinicaltrials.gov
Start Date
July 13, 2020
End Date
February 10, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rozalina G. McCoy

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Cognitive impairment precluding informed consent.
  • Lack of conversational English skills.
  • Resident of a long-term care facility.
  • Enrolled in hospice.
  • Enrolled in a care coordination or disease management program.
  • Advanced or terminal illness.

Outcomes

Primary Outcomes

Diabetes Distress (using DDS)

Time Frame: 1 month

The level of diabetes-related distress that is expressed by patient participants using the Diabetes Distress Scale (the DDS contains 17 questions, with responses ranging from "Not a Problem" (1) to "A Very Serious Problem" (6). Total scores use the sum of all responses divided by 17, with a mean item score of 3 or higher (moderate distress) indicating distress worthy of clinical attention.)

Secondary Outcomes

  • Health-Related Quality of Life (using EQ-5D)(1 and 4 months)
  • Diabetes Distress (using DDS)(4 months)
  • Self-Reported Hypoglycemia and Hyperglycemia(1 and 4 months)
  • Confidence in Diabetes Self-Management (using DSMQ)(1 and 4 months)

Study Sites (1)

Loading locations...

Similar Trials